For the second quarter of the fiscal year ending March 2027, consolidated net sales were 65,131 million yen, up 5.9% year-over-year. Operating income was 6,168 million yen, up 19.3% year-over-year; ordinary income was 5,620 million yen; and profit attributable to owners of parent was 3,578 million yen. Full-year forecasts were kept unchanged. Expansion of sales channels including newly acquired InterOptical and growth related to orthokeratology contributed. By segment, Vision Care remains the core, and Other businesses were steady.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7780","jir_company_name":"Menicon Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7780-20261113-01.pdf","jir_short_summary":"For the second quarter of the fiscal year ending March 2027, consolidated net sales were 65,131 million yen, up 5.9% year-over-year. Operating income was 6,168 million yen, up 19.3% year-over-year; ordinary income was 5,620 million yen; and profit attributable to owners of parent was 3,578 million yen. Full-year forecasts were kept unchanged. Expansion of sales channels including newly acquired InterOptical and growth related to orthokeratology contributed. By segment, Vision Care remains the core, and Other businesses were steady.","jir_summary":"### Overview of Results\nNet sales for the interim period were 65,131 million yen (up 5.9% YoY), driven by expanded domestic and international sales of the core daily disposable contact lenses and growth in MELS Plan membership. Operating income was 6,168 million yen (up 19.3% YoY), supported by higher gross profit and reductions in selling, general and administrative expenses. Ordinary income was 5,620 million yen (up 12.0% YoY), and profit attributable to owners of parent for the interim period was 3,578 million yen (up 13.5% YoY). Full-year forecasts remain unchanged.\n\n### Segment Performance & Strategy\nThe Vision Care segment recorded net sales of 60,471 million yen (up 5.6% YoY) and segment profit of 9,647 million yen (up 16.2% YoY). Profit growth was driven by expanded domestic and international sales of daily disposable lenses and strengthened sales of orthokeratology-related products. The Other segment achieved net sales of 4,661 million yen (up 10.9% YoY) with a segment loss of 305 million yen, driven by food business activities. The company continues to maintain and expand market share, particularly in China.","jir_financial_highlights":"Net Sales: 65,131 (Up 5.9% YoY)\nOperating Income: 6,168 (Up 19.3% YoY)\nOrdinary Income: 5,620 (Up 12.0% YoY)\nProfit Attributable to Owners of Parent (Interim): 3,578 (Up 13.5% YoY)\nEarnings per Share (Interim): 48.19 (Year-over-Year)","jir_category":"","jir_hashtags":"#Menicon, #Earnings, #Vision2030, #Orthokeratology","jir_key_figures":"Net Sales: 65,131 million yen (Up 5.9% YoY)\nOperating Income: 6,168 million yen (Up 19.3% YoY)\nProfit Attributable to Owners of Parent (Interim): 3,578 million yen (Up 13.5% YoY)","jir_meta_title":"Menicon Co., Ltd. \u2014 Q2 Interim Financial Summary for FY2027 | Net Sales 65,131 million yen, Operating Income 6,168 million yen","jir_meta_description":"Key points from Menicon Co., Ltd.'s Q2 interim financial summary for FY2027: net sales 65,131 million yen, operating income 6,168 million yen, profit attributable to owners of parent 3,578 million yen. Discusses Vision Care expansion, impact of recent acquisition and unchanged full-year outlook.","jir_og_title":"Menicon Co., Ltd.: Financial Summary for Q2 FY2027","jir_og_description":"Menicon Co., Ltd.'s interim results: net sales 65,131 million yen, operating income 6,168 million yen, profit attributable to owners of parent 3,578 million yen. Explains Vision Care growth and effects of recent acquisition.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2025\/4-9\\\",\\\"2026\/4-9\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[61480,65131]}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2025\/4-9\\\",\\\"2026\/4-9\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[5168,6168]}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Vision Care\\\",\\\"Other\\\"],\\\"datasets\\\":[{\\\"data\\\":[60471,4661]}]}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Margin Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2025\/4-9\\\",\\\"2026\/4-9\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin\\\",\\\"data\\\":[? , ?]}]}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Forecast vs. Actual Comparison\", \"jir_chart_json_data\": \"{\\\"headers\\\":[\\\"Item\\\",\\\"Actual 2026\/4-9\\\",\\\"Full-year Forecast\\\"],\\\"rows\\\":[[\\\"Net Sales\\\",\\\"65,131\\\",\\\"133,000\\\"]]}\"}]","ir_related_company":9426,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-151806","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n